Patent Applications published on Jun 2, 2022 - page 3

#601
US20220168142
Human necessities

BIOERODIBLE OCULAR DRUG DELIVERY INSERT AND THERAPEUTIC METHOD

#602
US20220168143
Human necessities

Systems and Methods for Generating and Applying Biomimicry Tear Films

#603
US20220168144
Human necessities

METHODS FOR LENTICULAR LASER INCISION

#604
US20220168145
Human necessities

TOOLS AND METHODS FOR DACRYOCYSTORHINOSTOMY

#605
US20220168146
Human necessities

INTRAOCULAR IMPLANTS AND RELATED KITS AND METHODS

#606
US20220168147
Human necessities

Implant Device for Eye Disease for Adjusting Intraocular Pressure

#607
US20220168148
Human necessities

SYSTEMS AND METHODS FOR LENTICULAR LASER INCISION

#608
US20220168149
Human necessities

EAR PROTECTION

#609
US20220168150
Human necessities

SYSTEM AND METHODS OF USE FOR PRE-CUT KINESIOLOGY TAPE EMBEDDED WITH MICROENCAPSULATED ESSENTIAL OILS

#610
US20220168151
Human necessities

PERFORATED BINDER FOR LAMINATED WOUND DRESSING

#611
US20220168152
Human necessities

ABSORBENT DRESSING WITH REMOTE MEASUREMENT OF DRESSING MOISTURE

#612
US20220168153
Human necessities

PROCESS FOR MAKING A COMPOSITE ELASTIC TAPE, ELASTIC TAPE SO OBTAINED AND PANTY DIAPER COMPRISING SAID ELASTIC TAPE

#613
US20220168154
Human necessities

INTERNET OF THINGS (IOT) SOLUTION FOR MANAGEMENT OF URINARY INCONTINENCE

#614
US20220168155
Human necessities

AUTOMATED INCONTINENCE MONITORING DIAPER, SYSTEM AND METHOD

#615
US20220168156
Human necessities

WIRELESS LOCATING OF AN INCONTINENCE DETECTION PAD VIA A PATIENT BED

#616
US20220168157
Human necessities

Crimped Fiber Spunbond Nonwoven Webs/Laminate

#617
US20220168158
Human necessities

COMPOSITE HAVING IMPROVED IN-PLANE PERMEABILITY AND ABSORBENT ARTICLE HAVING IMPROVED FLUID MANAGEMENT

#618
US20220168159
Human necessities

ABSORBENT PADS AND GARMENTS

#619
US20220168160
Human necessities

METHOD AND APPARATUS FOR DETERMINING PERSONNEL HARNESSING AND POSITION PROTOCOL ADHERENCE

#620
US20220168161
Human necessities

DRIVING WHEEL AND MOBILITY VEHICLE INCLUDING SAME

#621
US20220168162
Human necessities

Support device adjustable by an electric motor

#622
US20220168163
Human necessities

Bodily Transfer and Lifting Device

#623
US20220168164
Human necessities

NURSING-CARE DEVICE

#624
US20220168165
Human necessities

Wheeled Apparatus For Transporting A Portable Oxygen Concentrator Or Other Medical Device

#625
US20220168166
Human necessities

GAIT MOTION ASSISTING APPARATUS

#626
US20220168167
Human necessities

REHABILITATION ROBOT TRAINING SYSTEM FOR MONITORING AND SUPPRESSING COMPENSATORY MOVEMENT OF HEMIPLEGIC UPPER LIMB

#627
US20220168168
Human necessities

TRACK AND LIFT REHABILITATION SYSTEMS AND RELATED METHODS

#628
US20220168169
Human necessities

COLLAPSIBLE WALKING DEVICE

#629
US20220168170
Human necessities

A DEVICE FOR ALLEVIATING ITCHING

#630
US20220168171
Human necessities

PNEUMATIC COMPRESSION SYSTEMS AND COMPRESSION TREATMENT METHODS

#631
US20220168172
Human necessities

Wearable decentralized apparatus for optimal remote ischemic preconditioning

#632
US20220168173
Human necessities

MASSAGE APPARATUS

#633
US20220168174
Human necessities

MASSAGE TOY FOR SEXUAL STIMULATION

#634
US20220168175
Human necessities

NOVEL MASSAGE GUN

#635
US20220168176
Human necessities

Constrained and Repositionable Percussive Massage Device Tool and Tool Receiver

#636
US20220168177
Human necessities

Percussion Massager Having Variable and Selectable Stroke Length

#637
US20220168178
Human necessities

Adjustable massage structure and massage backpack

#638
US20220168179
Human necessities

PAIN MANAGEMENT DEVICE AND METHOD OF USE

#639
US20220168180
Human necessities

APPARATUS AND METHOD FOR TREATING A PATIENT USING VIBRATION STIMULI, TACTILE STIMULI AND/OR THERMAL STIMULI

#640
US20220168181
Human necessities

EMERGENCY WASH SYSTEM

#641
US20220168182
Human necessities

ULTRASONIC DEVICE AND CONTROL METHOD THEREOF

#642
US20220168183
Human necessities

SUBCUTANEOUS TISSUE THERAPY TREATMENT METHOD

#643
US20220168184
Human necessities

DEVICE FOR DISPENSING ACUPUNCTURE NEEDLE

#644
US20220168185
Human necessities

SYSTEM FOR LONG TIME STORAGE OF PHARMACEUTICAL COMPOSITIONS AT LOW TEMPERATURES

#645
US20220168186
Human necessities

Syringe Adapter with Aspiration Assembly

#646
US20220168187
Human necessities

DEVICE FOR MONITORING THE MEDICATION OF A PATIENT

#647
US20220168188
Human necessities

LOW COST AND UNIVERSAL PILL BOTTLE REGIMEN TRACKER WITH INTERCHANGEABLE LABELS

#648
US20220168189
Human necessities

NUTRITIONAL SUPPORT FEEDING EFFICIENCY

#649
US20220168190
Human necessities

Primer and kit of primer and dental material

#650
US20220168191
Human necessities

PROCESS FOR THE PREPARATION OF A READY-TO-USE, COSMETIC, FLOWABLE DETERGENT

#651
US20220168192
Human necessities

Cosmetic Cleansing Powder

#652
US20220168193
Human necessities

FLEXIBLE METAL PATCH HAVING ANTIOXIDANT ACTIVITY AND BRIGHTENING EFFECT AND METHOD FOR USING SAME

#653
US20220168194
Human necessities

MOUSSE PRODUCTS, METHODS AND DEVICES

#654
US20220168195
Human necessities

AN ANTIPERSPIRANT COMPOSITION COMPRISING REACTIVE SALTS

#655
US20220168196
Human necessities

ANHYDROUS SUNSCREEN COMPOSITION, PROCESS OF MANUFACTURING THE ANHYDROUS SUNSCREEN COMPOSITION AND USE OF THE ANHYDROUS SUNSCREEN COMPOSITION

#656
US20220168197
Human necessities

Powder System For The Care Of Hair

#657
US20220168198
Human necessities

AN ANTIMICROBIAL MIXTURE

#658
US20220168199
Human necessities

HIGH VISCOSITY GEL CLEANSING COMPOSITIONS

#659
US20220168200
Human necessities

AQUEOUS HAIR CONDITIONER COMPOSITIONS CONTAINING SOLUBILIZED ANTI-DANDRUFF ACTIVES

#660
US20220168201
Human necessities

USE OF DIANHYDROHEXITOL FOR PRESERVING COSMETIC PREPARATIONS

#661
US20220168202
Human necessities

AGENT FOR THE TREATMENT OF KERATINOUS FIBERS CONTAINING THE REACTION PRODUCT OF TWO ORGANIC C1-C6 ALKOXY SILANES AND WATER

#662
US20220168203
Human necessities

METHOD FOR PREPARING HAIR TREATMENTS AGENTS WITH ORGANIC C1-C6 ALKOXY-SILANES

#663
US20220168204
Human necessities

THE PROCESS OF DYEING KERATINOUS MATERIAL COMPRISING THE USE OF AN ORGANOSILICON COMPOUND, AN EFFECT PIGMENT, AND A FILM-FORMING POLYMER I

#664
US20220168205
Human necessities

METHOD FOR DYEING KERATINOUS MATERIAL, COMPRISING THE USE OF AN ORGANOSILICON COMPOUND, AN EFFECT PIGMENT AND A FILM-FORMING POLYMER II

#665
US20220168206
Human necessities

ACTIVE AGENT FOR USE IN HAIR GROWTH REGULATION

#666
US20220168207
Human necessities

COMPOSITIONS AND METHODS OF USE FOR TREATMENT OR IMPROVEMENT OF THE CONDITION AND APPEARANCE OF SKIN

#667
US20220168208
Human necessities

MICROBIAL ENZYMES TO REDUCE MALODOUR OF SKIN AND TEXTILES

#668
US20220168209
Human necessities

Sunscreen Compositions

#669
US20220168210
Human necessities

HIGH FOAMING CLEANSING COMPOSITION

#670
US20220168211
Human necessities

THE PROCESS OF COLORING KERATINOUS MATERIAL COMPRISING THE USE OF AN ORGANOSILICON COMPOUND, AN EFFECT PIGMENT, A FURTHER COLORING COMPOUND AND A FILM-FORMING POLYMER II

#671
US20220168212
Human necessities

Surfactant Systems for Zinc Containing Compositions

#672
US20220168213
Human necessities

WATER-IN-OIL EMULSION COMPOSITION

#673
US20220168214
Human necessities

GARLIC EXTRACT AND METHOD THEREOF

#674
US20220168215
Human necessities

USE OF COMPOSITION FOR REDUCING OR PREVENTING CELL AGING OR REPAIRING CELL WITH DAMAGED MITOCHONDRIA, METHOD OF PREPARING COMPOSITION FOR CELL REPAIRING, CELL REPAIRING METHOD AND METHOD OF SUPPLYING MITOCHONDRIA INTO CELL

#675
US20220168216
Human necessities

TOPICAL COMPOSITIONS AND METHODS OF USING THE SAME

#676
US20220168217
Human necessities

DRUG DELIVERY SILICONE COMPOSITION TO IMPROVE ACTIVE INGREDIENT ELUTION

#677
US20220168218
Human necessities

GEOMETRICALLY COMPLEX INTRAVAGINAL RINGS, SYSTEMS AND METHODS OF MAKING THE SAME

#678
US20220168219
Human necessities

LIQUID DEPOT FOR NON-INVASIVE SUSTAINED DELIVERY OF AGENTS TO THE EYE

#679
US20220168220
Human necessities

ANIMAL TREAT COMPOSITION FOR DELIVERY OF ORAL MEDICATION

#680
US20220168221
Human necessities

Methods and Compositions for Microdosing, Simulating Extended Release Formulations

#681
US20220168222
Human necessities

LIPID NANOPARTICLES

#682
US20220168223
Human necessities

LIPOSOMES ENCAPSULATING ADENOSINE

#683
US20220168224
Human necessities

MICROSPHERE COMPRISING PLGA OR PLA IN WHICH A BIOLOGICALLY ACTIVE SUBSTANCE IS UNIFORMLY DISPERSED AND A SUSTAINED RELEASE FORMULATION COMPRISING THE SAME

#684
US20220168225
Human necessities

DRY POWDER COMPOSITION COMPRISING LONG-CHAIN RNA

#685
US20220168226
Human necessities

SUBLINGUAL DELIVERY FOR MITIGATION OF SIDE EFFECTS ASSOCIATED WITH METFORMIN

#686
US20220168227
Human necessities

METHOD FOR PRODUCING HYDROGEL MICROCAPSULES, KIT FOR PRODUCING CAPSULES, AND USE THEREFOR

#687
US20220168228
Human necessities

Supraparticle Formulations

#688
US20220168229
Human necessities

BIODEGRADABLE EXTENDED RELEASE MICROSPHERE-HYDROGEL OCULAR DRUG DELIVERY SYSTEM AND METHOD

#689
US20220168230
Human necessities

NANOPARTICLE MEDIATED THERAPY

#690
US20220168231
Human necessities

SYNTHETIC LIPIDS FOR MRNA DELIVERY

#691
US20220168232
Human necessities

CAPSULE COMPRISING INSULIN-SECRETING CELLS FOR TREATING DIABETES

#692
US20220168233
Human necessities

HYDROGEL/NANOPARTICLE COMPLEX WITH TEMPERATURE SOL-GEL TRANSITION FOR SUSTAINED DRUG RELEASE

#693
US20220168234
Human necessities

LIPID NANOPARTICLES ENCAPSULATION OF LARGE RNA

#694
US20220168235
Human necessities

CANNABIGEROL AND PHARMACEUTICAL COMPOSITIONS COMPRISING CANNABIGEROL FOR USE IN THE TREATMENT OF INSOMNIA

#695
US20220168236
Human necessities

Paraffin Wax With CBD Isolate

#696
US20220168237
Human necessities

FLAVONOID POLYPHENOL DRUG SELF-EMULSIFYING COMPOSITION, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION THEREOF AND APPLICATION THEREOF

#697
US20220168238
Human necessities

METHODS AND COMPOSITIONS FOR USE IN TREATMENT OF CANCER WITHOUT PSYCHOACTIVE EFFECTS

#698
US20220168239
Human necessities

PREPARATION OF SOLUBLE FORM OF CURCUMIN

#699
US20220168240
Human necessities

CANCER THERAPY BY INTRATUMORAL INJECTION OF A CHEMOTHERAPEUTIC AGENT IN COMBINATION WITH A BIOACTIVE IMMUNOSTIMULATORY AGENT

#700
US20220168241
Human necessities

SUSTAINED RELEASE COMPOSITION COMPRISING TAPENTADOL AND METHOD OF PREPARATION THEREOF

#701
US20220168242
Human necessities

PHARMACEUTICALLY ACCEPTABLE SALTS OF MESDOPETAM AND USES THEREOF

#702
US20220168243
Human necessities

CORONAVIRUS TREATMENT COMPOSITIONS AND METHODS

#703
US20220168244
Human necessities

Bis-Biguanide Compounds, Pharmaceutical Compositions and Uses in Managing Cancer

#704
US20220168245
Human necessities

USE OF CANNABINOID 1 RECEPTOR AGONIST ARACHIDONOYL CYCLOPROPYLAMIDE (ACPA) IN NON SMALL CELL LUNG CANCER

#705
US20220168246
Human necessities

COMPOSITONS FOR THE TREATMENT OF A CONDITION CHARACTERIZED BY ANANDAMIDE DEFICIENCY AND USES THEREOF

#706
US20220168247
Human necessities

TOPICAL COMPOSITIONS FOR PAIN RELIEF, MANUFACTURE AND USE

#707
US20220168248
Human necessities

METHOD FOR TREATING MELANOMA

#708
US20220168249
Human necessities

METHODS OF TREATING DISEASE WITH DICHLORPHENAMIDE

#709
US20220168250
Human necessities

TRIPLE COMBINATION OF AN ERK1/2 INHIBITOR WITH A BRAF INHIBITOR AND AN EGFR INHIBITOR FOR USE IN THE TREATMENT OF BRAFv6ooE COLORECTAL CANCER

#710
US20220168251
Human necessities

PROCESS FOR PRODUCTION OF A NANO-MICROEMULSION SYSTEM OF FERULIC

#711
US20220168252
Human necessities

RETINOID DERIVATIVES WITH ANTITUMOR ACTIVITY

#712
US20220168253
Human necessities

PRODUCTION PROMOTER OF TYPE I COLLAGEN OR ELASTIN

#713
US20220168254
Human necessities

PARENTERAL NUTRITION FORMULATION WITH OPTIMIZED AMINO ACID AND GLUCOSE CONTENT

#714
US20220168255
Human necessities

PHARMACEUTICAL COMPOSITION CONTAINING DIMETHYL FUMARATE FOR ADMINISTRATION AT A LOW DAILY DOSE

#715
US20220168256
Human necessities

METHODS USING ADMINISTRATION OF MEDIUM CHAIN TRIGLYCERIDES (MCT) PRIOR TO A MEAL TO INCREASE KETONE PRODUCTION FROM THE MCTS

#716
US20220168257
Human necessities

METHODS USING MEDIUM CHAIN TRIGLYCERIDES ADMINISTERED PRIOR TO A MEAL TO DECREASE POSTPRANDIAL GLUCOSE FROM THE MEAL

#717
US20220168258
Human necessities

METHOD FOR TREATING FEMALE NON-SMOKERS WITH NON-SMALL CELL LUNG CANCER

#718
US20220168259
Human necessities

CHEMICAL DERIVATIVES AND METHODS FOR SYNTHESIZING AND COMPOUNDING CHEMICAL DERIVATIVES RELATED TO CAPSAICIN PALMITATE AND CAPSAICIN PRODRUGS

#719
US20220168260
Human necessities

Methods and Compositions to Treat and Diagnose Diseases or Pathologies Associated with Inflammation of the Sinuses and Nasal Cavity

#720
US20220168261
Human necessities

COMPOUNDS AND METHODS FOR MANAGING CANCER THROUGH IMMUNE SYSTEM

#721
US20220168262
Human necessities

AMPHIPHILIC PLATINUM (IV) PRODRUG AND CANCER TREATMENT PROCESS

#722
US20220168263
Human necessities

TREATMENT OF CIRCADIAN RHYTHM DISORDERS

#723
US20220168264
Human necessities

TREATMENT OF CIRCADIAN RHYTHM DISORDERS

#724
US20220168265
Human necessities

PHARMACEUTICAL COMPOSITION COMPRISING TETRAHYDROCANNABIVARIN FOR THE PREVENTION AND TREATMENT OF OVERWEIGHT

#725
US20220168266
Human necessities

CANNABIDIOL PREPARATIONS AND ITS USES

#726
US20220168267
Human necessities

METHODS OF TREATING AUTOIMMUNE MICROVASCULAR DISORDERS

#727
US20220168268
Human necessities

SMALL-MOLECULE INHIBITOR OF PD-1/PD-L1, PHARMACEUTICAL COMPOSITION THEREOF WITH PD-L1 ANTIBODY, AND APPLICATION OF SAME

#728
US20220168269
Human necessities

METHODS OF TREATING DISORDERS ASSOCIATED WITH GLYCOSYLATION DEFECTIVE PROTEINS

#729
US20220168270
Human necessities

COMPOSITIONS FOR PATHOGENESIS-DIRECTED THERAPY AND TREATMENTS OF SKIN DISEASES AND DISORDERS

#730
US20220168271
Human necessities

COMPOSITIONS AND METHODS FOR INCREASING T CELL FUNCTION

#731
US20220168272
Human necessities

PREPARATION OF SOLUBLE FORM OF CARVEDILOL

#732
US20220168273
Human necessities

Pharmaceutical Combination for the Treatment of Cancer

#733
US20220168274
Human necessities

Parenteral Formulation

#734
US20220168275
Human necessities

THERAPEUTIC COMPOSITIONS COMPRISING DEUTERATED OR PARTIALLY DEUTERATED N,N-DIMETHYLTRYPTAMINE COMPOUNDS

#735
US20220168276
Human necessities

Mehods and Compositions for Treating SARS-CoV-2 Infection using Carboxyamidotriazole Orotate

#736
US20220168277
Human necessities

DRUG INHIBITOR AGAINST MIGRATION AND INVASION OF CANCER CELLS AND METHODS OF TREATING AGAINST METASTASIS OF CANCER CELLS

#737
US20220168278
Human necessities

LOW DOSE FLURALANER COMPOSITIONS FOR PROTECTION AGAINST PARASITIC INVERTEBRATE PEST

#738
US20220168279
Human necessities

METHODS OF TREATING PAIN WITH A THIAZOLINE ANTI-HYPERALGESIC

#739
US20220168280
Human necessities

KRAS G12C INHIBITORS AND METHODS OF USING THE SAME

#740
US20220168281
Human necessities

NK-1 ANTAGONIST COMPOSITIONS AND METHODS FOR USE IN TREATING DEPRESSION

#741
US20220168282
Human necessities

INHIBITION OF COVID-19 VIRUS

#742
US20220168283
Human necessities

TREATMENT OF PROGRESSIVE NEURODEGENERATIVE DISEASE WITH IBUDILAST

#743
US20220168284
Human necessities

PHOSPHOINOSITIDE 3-KINASE INHIBITOR WITH A ZINC BINDING MOIETY

#744
US20220168285
Human necessities

PHARMACEUTICAL COMPOSITIONS

#745
US20220168286
Human necessities

TREATMENT OF RAYNAUD'S DISEASE

#746
US20220168287
Human necessities

Methods Of Treating Fabry Patients Having Renal Impairment

#747
US20220168288
Human necessities

Methods Of Treating Fabry Patients Having Renal Impairment

#748
US20220168289
Human necessities

Methods Of Treating Fabry Patients Having Renal Impairment

#749
US20220168290
Human necessities

Methods Of Treating Fabry Patients Having Renal Impairment

#750
US20220168291
Human necessities

Methods Of Treating Fabry Patients Having Renal Impairment

#751
US20220168292
Human necessities

Methods Of Treating Fabry Patients Having Renal Impairment

#752
US20220168293
Human necessities

TIME TO RESOLUTION OF AXITINIB-RELATED ADVERSE EVENTS

#753
US20220168294
Human necessities

TREATMENT OF CNS CONDITIONS

#754
US20220168295
Human necessities

RIMEGEPANT FOR CGRP RELATED DISORDERS

#755
US20220168296
Human necessities

METHODS OF TREATING CANCER WITH FARNESYLTRANSFERASE INHIBITORS

#756
US20220168297
Human necessities

METHODS AND COMPOSITIONS FOR TREATING CHRONIC OBSTRUCTIVE PULMONARY DISEASE, ASTHMA, PNEUMONIA, BRONCHITIS, CYSTIC FIBROSIS, PULMONARY EDEMA, INTERSTITIAL LUNG DISEASE, SARCOIDOSIS, IDIOPATHIC PULMONARY FIBROSIS, ACUTE RESPIRATORY DISTRESS SYNDROME, AND PULMONARY ARTERIAL HYPERTENSION

#757
US20220168298
Human necessities

CANCER TREATMENT

#758
US20220168299
Human necessities

PHARMACEUTICAL COMPOSITION COMPRISING TBN, OR SALT OR HYDRATE THEREOF, AND PREPARATION METHOD THEREOF

#759
US20220168300
Human necessities

Methods of Managing Vascular Conditions and Diabetic Peripheral Neuropathies

#760
US20220168301
Human necessities

METHODS FOR TREATING SYMPTOMATIC ORTHOSTATIC HYPOTENSION

#761
US20220168302
Human necessities

SALTS OF A COMPOUND, CRYSTAL FORMS OF THE SALTS AND PREPARATION METHOD AND USE THEREOF

#762
US20220168303
Human necessities

TREATMENT OF HER2 POSITIVE CANCERS

#763
US20220168304
Human necessities

METHODS FOR TREATING CYSTIC FIBROSIS

#764
US20220168305
Human necessities

Dosing Regimens Associated With Extended Release Paliperidone Injectable Formulations

#765
US20220168306
Human necessities

Dosing Regimens Associated With Extended Release Paliperidone Injectable Formulations

#766
US20220168307
Human necessities

TREATMENT OF SMA

#767
US20220168308
Human necessities

METHODS FOR TREATING ALZHEIMER DISEASE AND FOR REDUCING AMYLOID BETA FORMATION

#768
US20220168309
Human necessities

COMPOUNDS, COMPOSITIONS, AND METHODS FOR THE TREATMENT OF DISEASE

#769
US20220168310
Human necessities

INHIBITION OF ADENOVIRUS WITH FILOCICLOVIR

#770
US20220168311
Human necessities

THERAPEUTIC AGENT FOR PARKINSON'S DISEASE

#771
US20220168312
Human necessities

MULTICOMPONENT CRYSTAL FORMULATIONS

#772
US20220168313
Human necessities

HETEROCYCLIC COMPOUNDS AND USES THEREOF

#773
US20220168314
Human necessities

MEDICAMENT FOR PROPHYLAXIS OR TREATMENT OF PULMONARY FIBROSIS

#774
US20220168315
Human necessities

COMPOUNDS AND THERAPEUTIC USES THEREOF

#775
US20220168316
Human necessities

METHODS AND COMPOSITIONS FOR TREATING UREA CYCLE DISORDERS

#776
US20220168317
Human necessities

Therapeutic Thiazine Dye Compositions and Methods of Use

#777
US20220168318
Human necessities

PHARMACEUTICAL COMPOSITIONS AND METHODS FOR TREATMENT OF INSOMNIA

#778
US20220168319
Human necessities

COMBINED USE OF A-NOR-5alpha ANDROSTANE COMPOUND DRUG AND ANTICANCER DRUG

#779
US20220168320
Human necessities

HYALURONAN CONJUGATES WITH PHARMACEUTICALLY ACTIVE SUBSTANCES, METHODS AND COMPOSITIONS

#780
US20220168321
Human necessities

PHARMACEUTICAL CARRIERS CAPABLE OF pH DEPENDENT RECONSTITUTION AND METHODS FOR MAKING AND USING SAME

#781
US20220168322
Human necessities

NOVEL STAT3 INHIBITORS IDENTIFIED BY STRUCTURE-BASED VIRTUAL SCREENING INCORPORATING SH2 DOMAIN FLEXIBILITY

#782
US20220168323
Human necessities

CONCENTRATED LIQUID PHARMACEUTICAL FORMULATIONS OF FUROSEMIDE

#783
US20220168324
Human necessities

CANCER THERAPY

#784
US20220168325
Human necessities

METHODS TO PROMOTE CEREBRAL BLOOD FLOW IN THE BRAIN

#785
US20220168326
Human necessities

THERAPEUTIC COMBINATIONS COMPRISING ANTI-FOLR1 IMMUNOCONJUGATES

#786
US20220168327
Human necessities

Compounds for Treating and Preventing Net Associated Complications

#787
US20220168328
Human necessities

METHODS AND COMPOSITIONS FOR TREATING EUKARYOTIC INFECTIONS VIA ALTERING AGGREGATION DYNAMICS OF RAPTOR/KOG1

#788
US20220168329
Human necessities

COMBINATORIAL DRUG TREATMENT OF CANCER

#789
US20220168330
Human necessities

ANTIBODY DRUG CONJUGATES

#790
US20220168331
Human necessities

PRR-Activating and MicroRNA-Inhibiting Molecules and Methods of Using Same

#791
US20220168332
Human necessities

Multiplex shRNA for Use in Vectors

#792
US20220168333
Human necessities

Combination Treatment for Hematological Cancers

#793
US20220168334
Human necessities

SYSTEM AND METHOD TO REDUCE TISSUE ORORGAN ADHESION

#794
US20220168335
Human necessities

Hyaluronic Acid Derivatives for Wound Healing

#795
US20220168336
Human necessities

NITRIC OXIDE RELEASING SUPPOSITORIES AND METHODS OF USE THEREOF

#796
US20220168337
Human necessities

PRODUCING ATP AND IMPROVING MITOCHONDRIAL FUNCTION IN A MAMMAL USING A POLY-OXYGENATED METAL HYDROXIDE

#797
US20220168338
Human necessities

PREVENTION OF INFECTION BY HIGHLY PATHOGENIC VIRUSES USING TOPICAL APPLICATION OF POVIDONE-IODINE ON MUCOUS MEMBRANES

#798
US20220168339
Human necessities

Anti-Inflammatory Compositions and Methods

#799
US20220168340
Human necessities

UTILIZING THE INNATE IMMUNE SYSTEM TO DELIVER THERAPEUTIC AGENTS

#800
US20220168341
Human necessities

COMPOSITIONS AND METHODS OF TREATING DRY EYE SYNDROME AND OTHER TRAUMATIZED NON-KERATINIZED EPITHELIAL SURFACES

#801
US20220168342
Human necessities

GENOME EDITED PRIMARY B CELL AND METHODS OF MAKING AND USING

#802
US20220168343
Human necessities

CANCER IMMUNOTHERAPY USING COMBINATIONS OF CELLS EXPRESSING CHIMERIC ANTIGEN RECEPTORS AND MONOCLONAL ANTIBODIES

#803
US20220168344
Human necessities

COMPOSITIONS AND METHODS FOR TREATING CANCER WITH SELF-DRIVING CHIMERIC ANTIGEN RECEPTORS

#804
US20220168345
Human necessities

T CELL RECEPTORS AND METHODS OF USE THEREOF

#805
US20220168346
Human necessities

T CELL RECEPTORS AND METHODS OF USE THEREOF

#806
US20220168347
Human necessities

T CELL RECEPTORS AND METHODS OF USE THEREOF

#807
US20220168348
Human necessities

METHOD FOR CULTURING ALLOGENEIC IMMUNE CELL, IMMUNE CELL CULTURE OBTAINED THEREBY, AND IMMUNE CELL THERAPEUTIC AGENT COMPRISING SAME

#808
US20220168349
Human necessities

RECOMBINANT erIL-15 NK CELLS

#809
US20220168350
Human necessities

Lung Cancer Specific Marrow Infiltrating Lymphocytes and Uses Thereof

#810
US20220168351
Human necessities

TREATMENT OF A CANINE CD20 POSITIVE DISEASE OR CONDITION USING A CANINE CD20-SPECIFIC CHIMERIC ANTIGEN RECEPTOR

#811
US20220168352
Human necessities

CAR T-CELL ADJUVANT THERAPIES

#812
US20220168353
Human necessities

FREEZE-DRIED PLATELET DERIVATIVE COMPOSITIONS FOR TREATING ANTIPLATELET INDUCED COAGULOPATHY

#813
US20220168354
Human necessities

Compositions Comprising Milk Fat Globules

#814
US20220168355
Human necessities

Methods for Treating Conditions by Restoring Central Nervous System Endocrine Gland Function, and Compositions and Devices for Practicing the Same

#815
US20220168356
Human necessities

ALLOGRAFTS CONTAINING VIABLE CELLS AND METHODS THEROF

#816
US20220168357
Human necessities

METHOD FOR PRODUCING BIOLOGICAL TISSUE-LIKE STRUCTURE

#817
US20220168358
Human necessities

MITOCHONDRIAL TRANSPLANTATION AND USE THEREOF IN OCULAR DISEASES

#818
US20220168359
Human necessities

METHODS AND COMPOSITIONS FOR PRODUCING HEPATOCYTE-LIKE CELLS

#819
US20220168360
Human necessities

COMPOSITIONS, DEVICES, AND METHODS FOR TREATING RESPIRATORY DISORDERS

#820
US20220168361
Human necessities

METHODS FOR MEASURING THERAPEUTIC EFFECTS OF RETINAL DISEASE THERAPIES

#821
US20220168362
Human necessities

BACTERIA ENGINEERED TO TREAT DISORDERS INVOLVING THE CATABOLISM OF A BRANCHED CHAIN AMINO ACID

#822
US20220168363
Human necessities

COMPOSITIONS CONTAINING BACILLAENE PRODUCING BACTERIA OR PREPARATIONS THEREOF

#823
US20220168364
Human necessities

MODIFIED MICROORGANISMS EXPRESSING SAGA AND RELATED COMPOSITIONS FOR IMMUNOMODULATION AGAINST INFECTION AND CANCER IMMUNOTHERAPY

#824
US20220168365
Human necessities

LACTIC ACID BACTERIA, METHODS AND USES THEREOF

#825
US20220168366
Human necessities

NUTRACEUTICAL COMPOSITIONS

#826
US20220168367
Human necessities

Destroying Cancer Cells While Maintaining Healthy Cell Integrity

#827
US20220168368
Human necessities

RECOMBINANT ONCOLYTIC VIRUS, PREPARATION METHOD THEREFOR, USE THEREOF AND MEDICINE THEREOF

#828
US20220168369
Human necessities

NUTRITIONAL COMPOSITION

#829
US20220168370
Human necessities

ELASTASE ACTIVITY INHIBITOR, ELASTASE ACTIVITY INHIBITING TOPICAL AGENT, AND ELASTASE ACTIVITY INHIBITING FOOD AND BEVERAGE COMPOSITION

#830
US20220168371
Human necessities

A Product and Process For A Room-Temperature Stable, Food-Grade, All-Natural, Vegan, And Phyto-Cannabinoid/Terpene/Flavonoid Colloidal Dispersion

#831
US20220168372
Human necessities

FASTING-MIMICKING DIET PROMOTES CANCER-FREE SURVIVAL IN ACUTE LYMPHOBLASTIC LEUKEMIA MODELS

#832
US20220168373
Human necessities

CONTROLLED CANNABIS DECARBOXYLATION FOR AN INFUSED SOLUBLE FAT PRODUCT

#833
US20220168374
Human necessities

FOOD SUPPLEMENT COMPOSITION WITH FUNCTIONAL ACTIVES IN THE FORM OF A LIPSTICK

#834
US20220168375
Human necessities

TEA COMPOSITION HAVING EFFICACY FOR PREVENTING OR IMPROVING RESPIRATORY DISEASES, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME

#835
US20220168376
Human necessities

METHODS FOR ENHACEMENT OF DEHYDROEPIANDROSTERONE USING GREEN COFFEE BEAN EXTRACT

#836
US20220168377
Human necessities

PEPTIDE COMPOSITION FROM EARLY HARVESTED RICE AND METHODS FOR SLIMMING OR PROMOTING GROWTH OF PROBIOTICS USING THE SAME

#837
US20220168378
Human necessities

BIOAVAILABLE TURMERIC COMPOSITION AND PROCESS FOR PREPARATION THEREOF

#838
US20220168379
Human necessities

LIPOPROTEIN TARGETING PROTEASE INHIBITORS AND USES

#839
US20220168380
Human necessities

FORMULATIONS FOR TREATING CRAMPS AND SPASMS

#840
US20220168381
Human necessities

FORMULATIONS CONTAINING A SOMATOSTATIN RECEPTOR AGONIST

#841
US20220168382
Human necessities

Pharmaceutical composition and method for relieving/eliminating morphine-induced analgesic tolerance

#842
US20220168383
Human necessities

NEUROTENSINERGIC AGONISTS AND METHODS OF USING SAME PREVENTING OR TREATING PAIN

#843
US20220168384
Human necessities

Anti-Bacterial Combination Therapy

#844
US20220168385
Human necessities

USE OF CYCLOSPORINE ANALOGUES AS ANTITHROMBOTIC AGENTS

#845
US20220168386
Human necessities

NOVEL PSMA SPECIFIC BINDING PROTEINS FOR CANCER DIAGNOSIS AND TREATMENT

#846
US20220168387
Human necessities

INHALED ADMINISTRATION OF LIPOCALIN MUTEINS

#847
US20220168388
Human necessities

METHODS AND COMPOSITIONS FOR TUSC2 IMMUNOTHERAPY

#848
US20220168389
Human necessities

METHODS OF MAKING CHIMERIC ANTIGEN RECEPTOR-EXPRESSING CELLS

#849
US20220168390
Human necessities

METHOD TO INHIBIT NEUTROPHIL RECRUITMENT TO DAMAGED TISSUE USING MYELOID-DERIVED GROWTH FACTOR

#850
US20220168391
Human necessities

USE OF EPIDERMAL GROWTH FACTOR IN DIABETIC FOOT ULCER TREATMENT

#851
US20220168392
Human necessities

Methods of Enhancing Protection Against Organ and Vascular Injury, Hematopoietic Recovery and Survival in Response to Total Body Radiation/Chemical Exposure

#852
US20220168393
Human necessities

IL-12 COMPOSITIONS AND METHODS OF USE IN HEMATOPOIETIC RECOVERY

#853
US20220168394
Human necessities

METHODS OF INDUCING OR RESTORING IMMUNE TOLERANCE

#854
US20220168395
Human necessities

COMBINED PHARMACEUTICAL COMPOSITION

#855
US20220168396
Human necessities

MULTI-RECEPTOR AGONIST AND MEDICAL USE THEREOF

#856
US20220168397
Human necessities

TREATMENT OF PATIENTS WITH SEVERE VON WILLEBRAND DISEASE UNDERGOING ELECTIVE SURGERY BY ADMINISTRATION OF RECOMBINANT VWF

#857
US20220168398
Human necessities

Hemostatic agent and container containing the same

#858
US20220168399
Human necessities

FORMULATIONS FOR NUTRITIONAL SUPPORT IN SUBJECTS IN NEED THEREOF

#859
US20220168400
Human necessities

USE OF A MANGANESE SUPEROXIDE DISMUTASE WITH HIGH STABILITY IN THE PREVENTION OR TREATMENT OF CEREBRAL STROKE

#860
US20220168401
Human necessities

SUPER-OXIDE DISMUTASE SOLUBLE FIBER COMPOSITIONS

#861
US20220168402
Human necessities

PIP4Ks SUPPRESS INSULIN SIGNALING AND ENHANCE IMMUNE FUNCTION THROUGH A CATALYTIC-INDEPENDENT MECHANISM

#862
US20220168403
Human necessities

SUBCUTANEOUS TELOMERASE INHIBITOR COMPOSITIONS AND METHODS FOR USING SAME

#863
US20220168404
Human necessities

METHODS AND COMPOSITIONS FOR THE TREATMENT OF CORONAVIRUS INFECTION, INCLUDING SARS-COV-2

#864
US20220168405
Human necessities

TREATMENT OF PRURITUS IN HORSES

#865
US20220168406
Human necessities

CANCER VACCINES AGAINST MUCOSAL ANTIGENS AND METHODS OF MAKING AND USING THE SAME

#866
US20220168407
Human necessities

USE OF TUMOR-INDEPENDENT ANTIGENS IN IMMUNOTHERAPIES

#867
US20220168408
Human necessities

MULTI-VALENT IMMUNOTHERAPY COMPOSITION AND METHODS OF USE FOR TREATING WT1-POSITIVE CANCERS

#868
US20220168409
Human necessities

VACCINES

#869
US20220168410
Human necessities

ESCHERICHIA COLI COMPOSITIONS AND METHODS THEREOF

#870
US20220168411
Human necessities

PSORALEN-INACTIVATED CORONAVIRUS VACCINE AND METHOD OF PREPARATION

#871
US20220168412
Human necessities

Chimeric Zika-Japanese Encephalitis Virus

#872
US20220168413
Human necessities

ADJUVANTED MULTIVALENT INFLUENZA VACCINES

#873
US20220168414
Human necessities

MULTIVALENT CARRIERS AND RELATED VACCINE COMPOSITIONS

#874
US20220168415
Human necessities

EXTRACELLULAR VESICLES FOR VACCINE DELIVERY

#875
US20220168416
Human necessities

Afucosylated Anti-FGFR2IIIB Antibodies

#876
US20220168417
Human necessities

COMBINATION THERAPY WITH AN ANTI BCMA ANTIBODY AND A GAMMA SECRETASE INHIBITOR

#877
US20220168418
Human necessities

PREVENTION OR MITIGATION OF T-CELL ENGAGING AGENT-RELATED ADVERSE EFFECTS

#878
US20220168419
Human necessities

COMPOSITIONS AND METHODS FOR TREATING AUTOIMMUNE DISEASES AND CANCERS

#879
US20220168420
Human necessities

NOVEL ANTI-LAM AND ANTI-PIM6/LAM MONOCLONAL ANTIBODIES FOR DIAGNOSIS AND TREATMENT OF MYCOBACTERIUM TUBERCULOSIS INFECTIONS

#880
US20220168421
Human necessities

PHOTOTHERMAL THERAPY PROMOTES TUMOR INFILTRATION AND ANTITUMOR ACTIVITY OF CART T CELLS

#881
US20220168422
Human necessities

COMPOSITIONS AND METHODS FOR MONITORING, DIAGNOSIS, PROGNOSIS, DETECTION, AND TREATMENT OF CANCER

#882
US20220168423
Human necessities

NANOPARTICLES OF INDIRUBIN, DERIVATIVES THEREOF AND METHODS OF MAKING AND USING SAME

#883
US20220168424
Human necessities

THERMALLY STABLE ANTIBACTERIAL QUATERNARY AMMONIUM NANOPARTICLES

#884
US20220168425
Human necessities

COMPOSITIONS FOR RETARDING THE DECOMPOSITION OF MELATONIN IN SOLUTION

#885
US20220168426
Human necessities

BIOORTHOGONAL COMPOSITIONS

#886
US20220168427
Human necessities

METHODS AND COMPOSITIONS FOR TARGETED PROTEIN DEGRADATION

#887
US20220168428
Human necessities

CANNABINOID GLYCOSIDE PRODRUGS AND METHODS OF SYNTHESIS

#888
US20220168429
Human necessities

NUCLEIC ACID MAZZOCCHIO AND METHODS OF MAKING AND USE THEREOF

#889
US20220168430
Human necessities

THERAPEUTIC METHODS FOR TREATING HEPATITIS B

#890
US20220168431
Human necessities

METHODS OF TREATING CANCER USING TRIMETAZIDINE-BASED COMPOUNDS

#891
US20220168432
Human necessities

MODIFIED RELEASE FORMULATIONS CONTAINING DRUG-ION EXCHANGE RESIN COMPLEXES

#892
US20220168433
Human necessities

PROGRAMMABLE POLYMERIC DRUGS

#893
US20220168434
Human necessities

APPLICATION OF TRANSTHYRETIN IN ENTERING EYE AND PREPARING DROP

#894
US20220168435
Human necessities

PROGRAMMABLE POLYMERIC DRUGS

#895
US20220168436
Human necessities

ANTIBODY DRUG CONJUGATES

#896
US20220168437
Human necessities

ANTIBODY-DRUG CONJUGATES TARGETING CLAUDIN 18.2

#897
US20220168438
Human necessities

COMBINATION OF ANTIBODY-PYRROLOBENZODIAZEPINE DERIVATIVE CONJUGATE AND PARP INHIBITOR

#898
US20220168439
Human necessities

METHODS AND COMPOSITIONS FOR REDUCING METASTASES

#899
US20220168440
Human necessities

ANTIBODY-PYRROLOBENZODIAZEPINE DEPRIVATIVE CONJUGATE

#900
US20220168441
Human necessities

Polynucleotide-Linked Bioconjugates and Methods of Making and Using